ABOUT THIS REPORT
AfroCentric Investment Corporation Limited (“AfroCentric”, “the AfroCentric Group”, or “the Group”) is pleased to present its Integrated Report (“report”) for the year ended 30 June 2017. This report is primarily addressed to our current and prospective investors and other relevant stakeholders.
Value
We define value as the ability to use our resources to sustain financial returns, transform the lives of our key stakeholders, and ensure the preservation of our natural environment.
Materiality
AfroCentric’s definition of materiality is derived from the IIRC’s Framework. The Group’s material matters are those matters that substantively affect our ability to create value over the short, medium and long term.
OUR STORY
The Group has grown significantly since listing on the Johannesburg Stock Exchange (“JSE”) in 2008, and it continues making access to sustainable quality healthcare affordable for everyone.
PERFORMANCE SUMMARY FOR THE YEAR

DIVIDEND INCREASED BY 16.67% TO 28 CENTS PER SHARE FOR THE YEAR

18% INCREASE IN SHARE PRICE

TOTAL REVENUE INCREASE BY 20.22%

AMALGAMATION OF BONITAS MEDICAL AID FUND ("BONITAS") AND LMS MEDICAL FUND ("LIBERTY") INCREASED THE NUMBER OF LIVES UNDER OUR CARE BY APPROXIMATELY 125 000

COMPANY HISTORY
A journey of growth and integration in the healthcare value chain.
W.B. Holdings (cash shell on the JSE).
AfroCentric purchased the AfroCentric Health Proprietary Limited (“AHL”) Group (80% shareholding).
Helios IT Solutions acquired a 51% interest in Allegra.

Sanlam acquired 28.7% of AfroCentric Healthcare Assets, a major subsidiary of AfroCentric.

AfroCentric was awarded the POLMED scheme contract.

AfroCentric acquired 100% of Pharmacy Direct, 100% of Curasana and 26% of Activo Health.

AHL, the largest operational subsidiary of the Group, repurchased its outstanding 5.9% minority interest. AHL became a private company effective July 2016.

AfroCentric is incorporated (80% of share capital purchased) and listed on the JSE.<
AfroCentric increased its shareholding in AHL to 94.1%.
AfroCentric acquired the South African licence of the DBC back and neck rehabilitation programme.

The amalgamation of Bonitas and LMS Medical Fund (“Liberty”) added approximately 125 000 more lives under our care.

Pharmacy Direct secured further contracts for the delivery of chronic medication to scheme members and extended its government CCMDD contract to seven South African provinces (previously five).

AfroCentric acquired “The Cheese Has Moved” (1 March 2017) which will improve sales.

AfroCentric acquired the “Wellness Odyssey” (effective 1 July 2017) which has the wellness and managed care capabilities to improve health offerings to scheme members.